Rotigotine transdermal system for the treatment of Parkinson's disease
- 31 May 2008
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 30 (5) , 813-824
- https://doi.org/10.1016/j.clinthera.2008.05.007
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Rotigotine Transdermal PatchCNS Drugs, 2007
- Clinical studies with transdermal rotigotine in early Parkinson’s diseaseNeurology, 2005
- RotigotineCNS Drugs, 2005
- Parkinson's diseaseThe Lancet, 2004
- An algorithm (decision tree) for the management of Parkinson’s disease (2001):Neurology, 2001
- Pramipexole vs Levodopa as Initial Treatment for Parkinson DiseaseJAMA, 2000
- RopiniroleDrugs, 2000
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- Pharmacokinetic Characterisation of Transdermal Delivery SystemsClinical Pharmacokinetics, 1994
- N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's diseaseMovement Disorders, 1994